Amoy Diagnostics Co Ltd

Chart & performance

D1W1MN

P/E

19.19

P/S

5.79

EPS

0.93

Div yield, %

1.69%

Shrs. gr., 5y

-0.08%

Rev. gr., 5y

5.48%

Revenues

Net income

CFO

Dividend

May 18, 20260.45 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Amoy Diagnostics Co., Ltd. is a Chinese company focused on oncology precision medicine. It engages in the research, development, production, and sale of molecular diagnostic products. The company provides a range of diagnostic reagents and testing services that help identify genetic mutations and biomarkers, which are used to guide personalized cancer treatment.

URL

https://www.amoydx.com/

IPO date

Aug 02, 2017

Employees

Domiciled in

Incorporated in

Valuation

No data to show